Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02800 TRACKER FUND
RT Nominal unchange25.140 0.000 (0.000%)

25/08/2026 19:07

GIC increases stake in Hengrui Medicine (01276) by 3.66 million H-shares, raising holding to 15.7%

The Economic Times reported on the 25th that according to exchange filing data, Singapore's Government Investment Corporation (GIC Private) increased its stake in Hengrui Medicine (01276) by 3.66 million H-shares on last Thursday (20th), at an average price of HK$50.5655 per share, involving a total amount of HK$185 million, raising its latest stake to 15.7%. (bi)

Back to Block Trade News

Remark: Real time quote last updated: 30/09/2026 08:25
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.